Diagnostic Testing Fund – Adult Oncology: Hematologic/Blood Cancers

This fund supports adults with signs or imaging results that may indicate a rare sarcoma, such as liposarcoma or osteosarcoma. It provides access to genetic and precision biomarker testing to help accurately identify the tumor type and guide the care team’s approach. These diagnostics are especially important when the disease is fast-moving or has already spread, helping ensure timely decisions around surgery, chemotherapy, or clinical trial options.